There is a nonsignificant trend toward lower rates of pre– and post–allo-HSCT relapse rates with RIT plus a TKI than with IC plus a TKI (pre–allo-HSCT RR of 0.26 [95% CI, 0.03-2.18]; post–allo-HSCT RR of 0.65 [95% CI, 0.2-2.11]).
← all excerpts
American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults.
2
—
—
The sentences
The panel highlighted that the consequences of CNS relapse, and its treatment, are likely to be significant and underrecognized.